ISRCTN20328848
Completed
未知
Primary Prevention Of Psychosis through interventions in the symptomatic prodromal phase. A pragmatic Norwegian Ultra High Risk study.
Stavanger University Hospital (Norway)0 sites240 target enrollmentOctober 31, 2014
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- Stavanger University Hospital (Norway)
- Enrollment
- 240
- Status
- Completed
- Last Updated
- 9 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Incidence study inclusion criteria:
- •1\. The patient is listed in the national register and residing in the catchment areas of Stavanger, Fonna, Bergen, and Østfold
- •2\. Between 13 and 65 years
- •3\. Meet diagnostic criteria in DSM\-IV for first episode schizophrenia, schizophreniform disorder, schizoaffective disorder, delusional disorder, brief psychotic disorder, affective psychoses (Bipolar I disorder, Bipolar II disorder with psychotic symptoms, Major depressive disorder with psychotic symptoms) or psychotic disorders NOS
- •4\. The patient is (or has recently been) active psychotic with symptoms of delusions, hallucinations, disturbed thinking, unsuitable/bizarre behaviour which cannot clearly be explained by organic reasons. The symptoms must have lasted the whole day for several days or several times a week for several weeks, not limited to some brief moments corresponding to a score of at least 4 on one or more of the following positive and negative symptom scale (PANSS) symptoms: P1 (delusions), P3 hallucinations), P5 (grandiose thinking), P6 (suspiciousness) and G9 (unusual thought content); 5\. This is the first episode of the condition that is being adequately treated. i.e. the patient has not received antipsychotic treatment corresponding to 75% of a defined daily dosage for more than eight weeks (shorter if the symptoms remit)
- •6\. There are no known neurological or endocrine disorders that may have caused the presenting psychotic symptoms
- •7\. The patient is not mentally retarded with an IQ below 70
- •8\. Able to understand and speak Norwegian
- •9\. Able to understand and sign informed consent/assent for minors' document.
- •Prodromal inclusion and exclusion criteria
Exclusion Criteria
- •All referals not fullfilling inclusion criteria described above
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The prevention of psychosis in at risk mental stateISRCTN21353122The Netherlands Organisation for Health Research and Development (ZonMw) (The Netherlands)240
Completed
Not Applicable
Prevention of psychosis with a cognitive behavioural intervention in help-seeking young people with an at risk mental state for developing psychosisNL-OMON31359Parnassia (Den Haag)240
Completed
Phase 4
Second generation intervention research in the pre-psychotic phase of illness in schizophrenia and related psychosesSchizophrenia and other psychotic disordersMental Health - SchizophreniaMental Health - Other mental health disordersACTRN12605000247673Janssen-Cilag Pharmaceuticals119
Recruiting
Phase 3
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trialinvestigating the efficacy of N-Acetylcysteine (NAC) and Integrated Preventive PsychologicalIntervention (IPPI) in Subjects Clinically at High Risk for PsychosisSubjects presenting ultra-high risk (UHR) for psychosis (e.g. attenuated psychotic symptoms, brief limited intermittend psychotic symptoms or a genetic risk in combination with a decline in social functioning)DRKS00010952Zentralinstitut für seelische Gesundheit/Central Institute of Mental Health (ZI)200
Active, not recruiting
Phase 1
Multimodal Prevention of First Psychotic Episode – a 2x2-Factorial Randomized Trial investigating the efficacy of Acetylcysteine (ACC) and Integrated Preventive Psychological Intervention (IPPI) in Subjects Clinically at High Risk for PsychosisEUCTR2014-003076-22-DECentral Institute of Mental Health Mannheim (ZI)130